Trial Profile
A Phase I Evaluation of Cetuximab and RAD001 in Patients With Solid Tumors
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 18 Jul 2012
Price :
$35
*
At a glance
- Drugs Cetuximab (Primary) ; Everolimus (Primary)
- Indications Colon cancer; Head and neck cancer
- Focus Adverse reactions; Biomarker
- 18 Jul 2012 New trial record